作者
Laure Gossec, Josef S Smolen, Sofia Ramiro, M De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, Robert Landewe, Susan Oliver, Daniel Aletaha, Neil Betteridge, Juergen Braun, G Burmester, Juan D Canete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, P Helliwell, TK Kvien, Rik Lories, Thomas Luger, Mara Maccarone, Helena Marzo-Ortega, Dennis McGonagle, Iain B McInnes, Ignazio Olivieri, Karel Pavelka, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J Veale, Juergen Wollenhaupt, Angela Zink, D Van Der Heijde
发表日期
2016/3/1
期刊
Annals of the rheumatic diseases
卷号
75
期号
3
页码范围
499-510
出版商
BMJ Publishing Group Ltd
简介
Background
Since the publication of the European League Against Rheumatism recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence and new therapeutic agents have emerged. The objective was to update these recommendations.
Methods
A systematic literature review was performed regarding pharmacological treatment in PsA. Subsequently, recommendations were formulated based on the evidence and the expert opinion of the 34 Task Force members. Levels of evidence and strengths of recommendations were allocated.
Results
The updated recommendations comprise 5 overarching principles and 10 recommendations, covering pharmacological therapies for PsA from non-steroidal anti-inflammatory drugs (NSAIDs), to conventional synthetic (csDMARD) and biological (bDMARD) disease-modifying antirheumatic drugs, whatever their mode of action, taking …
学术搜索中的文章
L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo… - Annals of the rheumatic diseases, 2016